Clinical Trial Update: A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating GSK189254 and duloxetine in an electrical hyperalgesia model in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia

Drugs mentioned

• Duloxetine (DULOXETINE)
• GSK189254

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hyperalgesia | Phase 1 | Status: COMPLETED